Burden of diabetes, hyperglycaemia in China from to 2016: Findings from the 1990 to 2016, global burden of disease study

Diabetes and Metabolism

Volumn 45, Issue 3, 2019, Pages 286-293

  Liu, M ^a,b   Liu, S W ^b   Wang, L J ^b   Bai, Y M ^b   Zeng, X Y ^b   Guo, H B ^c   Liu, Y N ^b   Jiang, Y Y ^b   Dong, W L ^b   He, G X ^a   Zhou, M G ^b   Yu, S C ^b  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b National Center for Chronic and Noncommunicable Disease Control and Prevention   (China)

^c International Union Against Tuberculosis and Lung Disease ^*  (China)

Author keywords

Burden of diabetes; China; Epidemiology; Hyperglycaemia

Indexed keywords

GLUCOSE;

ADOLESCENT; ADULT; AGE; AGED; ANALYTICAL RESEARCH; ARTICLE; ATTRIBUTABLE RISK; BODY MASS; CHILD; CHINA; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DIABETIC PATIENT; DIET; DISABILITY-ADJUSTED LIFE YEAR; DISEASE BURDEN; FASTING; FEMALE; FRUIT; GENDER; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; NUT; PASSIVE SMOKING; PHYSICAL ACTIVITY; PLANT SEED; PREVALENCE; PROCESSED MEAT; RED MEAT; RISK FACTOR; SMOKING; SUGAR-SWEETENED BEVERAGE; TREND STUDY; WHOLE GRAIN; GLOBAL DISEASE BURDEN; MIDDLE AGED; MORTALITY; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHINA; DIABETES MELLITUS; FEMALE; GLOBAL BURDEN OF DISEASE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PREVALENCE; SURVIVAL RATE; YOUNG ADULT;

EID: 85054164156     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2018.08.008     Document Type: Article

References (38)

1. GBD 2016 Causes of Death Collaborators Naghavi, M, Abajobir, AA, Abbafati, C, Abbas, KM, Abd-Allah, F, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the global burden of disease study 2016. Lancet 390 (2017), 1151–1210.
2. GBD 2016 DALYs and HALE Collaborators Hay, SI, Abajobir, AA, Abate, KK, Abbafati, C, Abbas, KM, et al. Global, regional, and national disability-adjusted life years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet 390 (2017), 1260–1344.
3. World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013–2020, 2013, WHO document production services, Geneva, Switzerland, 948–949.
4. Weil, AR, The growing burden of non-communicable diseases. Health affairs, 34, 2015, 1439.
5. World Health Organization. Preventing chronic diseases: a vital investment, 126, 2010, WHO document production services, Geneva, Switzerland, 95.
6. Zhang, P, Gregg, E, Global economic burden of diabetes and its implications. Lancet Diabetes Endocrinol 5 (2017), 404–405.
7. International Diabetes Federation. IDF diabetes atlas, 8th ed., 2017, International Diabetes Federation, Brussels, Belgium.
8. Chinese Center for Disease Control and Prevention. Main results of 2010 chronic disease and risk factors surveillance in disease surveillance points system, 2011, Chinese Center for Disease Control and Prevention, China CDC, Beijing, China.
9. Wang, Y, Prevalence of diabetes among men and women in China. N Engl J Med 362 (2010), 1090–1101.
10. Li, LM, Rao, KQ, Kong, LZ, Yao, CH, Xiang, HD, Zhai, FY, et al. A description on the Chinese national nutrition and health survey in 2002. Chin J Epidemiol, 26, 2005, 478.
11. National Health Commission of the People's Republic of China. Report on Chinese residents’ chronic disease and nutrition 2015, 2015, People's Medical Publishing House, Beijing.
12. Li, Y, Wang, DD, Ley, SH, Vasanti, M, Howard, AG, He, Y, et al. Time trends of dietary and lifestyle factors and their potential impact on diabetes burden in China. Diabetes care 40 (2017), 1685–1694.
13. Wang, L, Gao, P, Zhang, M, Huang, Z, Zhang, D, Deng, Q, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. Jama, 317, 2017, 2515.
14. GBD 2016 Risk Factors Collaborators Gakidou, E, Afshin, A, Abajobir, AA, Abate, KH, Abbafati, C, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet 390 (2017), 1345–1422.
15. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators Vos, T, Abajobir, AA, Abbafati, C, Abbas, KM, Abate, KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet 390 (2017), 1211–1259.
16. Moradi-Lakeh, M, Forouzanfar, MH, El Bcheraoui, C, Daoud, F, Afshin, A, Hanson, SW, et al. High fasting plasma glucose, diabetes, and its risk factors in the eastern Mediterranean region, 1990–2013: findings from the global burden of disease study 2013. Diabetes Care 40 (2017), 22–29.
17. Costa, AF, Flor, LS, Campos, MR, Oliveira, AF, Costa, MF, Silva, RS, et al. Burden of type 2 diabetes mellitus in Brazil. Cad Saude Publica, 33, 2017, e00197915.
18. Duncan, BB, Schmidt, MI, Ewerton, C, Moradi-Lakeh, M, Passos, VA, França, EB, et al. The burden of diabetes and hyperglycemia in Brazil – past and present: findings from the Global Burden of Disease Study 2015. Diabet Metab Syndr, 9, 2017, 18.
19. Salomon, JA, Haagsma, JA, Davis, A, de Noordhout, CM, Polinder, S, Havelaar, AH, et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Global Health, 3, 2015, e712.
20. Menke, A, Casagrande, S, Geiss, L, Cowie, CC, Prevalence of and trends in diabetes among adults in the United States 1988–2012. JAMA 314 (2015), 1021–1918.
21. Hu, C, Jia, W, Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication. Diabetes 67 (2018), 3–11.
22. Yang, W, Lu, J, Weng, J, Jia, W, Ji, L, Xiao, J, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 362, 2010, 2425.
23. Yang, G, Wang, Y, Zeng, Y, Gao, F, Zhou, M, Wan, X, et al. Rapid health transition in China, 1990–2010: findings from the global burden of disease study 2010. Lancet 381 (2013), 1987–2015.
24. Global Burden of Metabolic Risk Factor for Chronic Diseases Collaboration Lu, Y, Hajifathalian, K, Ezzati, M, Woodward, M, Rimm, EB, et al. Metabolic mediators of the effects of body mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet 383 (2014), 970–983.
25. Gonzalez, ABD, Hartge, P, Cerhan, JR, Flint, AJ, Hannan, L, Macinnis, RJ, et al. Body mass index and mortality among 1.46 million white adults. N Engl J Med 363 (2010), 2211–2219.
26. Singh, GM, Danaei, G, Farzadfar, F, Stevens, GA, Woodward, M, Wormser, D, et al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS ONE, 8, 2013, 65174.
27. Whitlock, Lewington, G, Sherliker, S, Clarke, P, Emberson, R, Halsey, J, et al. Body mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet 373 (2009), 1083–1096.
28. Wormser, D, Kaptoge, S, Di, AE, Wood, AM, Pennells, L, Thompson, A, et al. Separate and combined associations of body mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 377 (2011), 1085–1095.
29. Zheng, W, Mclerran, DF, Rolland, B, Zhang, X, Inoue, M, Matsuo, K, et al. Association between body mass index and risk of death in more than 1 million Asians. N Engl J Med, 364, 2011, 719.
30. NDC Risk Factor Collaboration. Trends in adult body mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet, 387, 2016, 1377.
31. Su, C, Zhang, B, Wang, HJ, Ww, DU, Liu, AD, Zhang, JG, et al. The status and trend of cereal consumption among Chinese adults in nine provinces (municipality) from 1989 to 2006. Zhonghua Yu Fang Yi Xue Za Zhi, 45, 2011, 798.
32. Zhai, F, Wang, H, Du, S, He, Y, Wang, Z, Ge, K, et al. Prospective study on nutrition transition in China. Nutrit Rev 67 (2010), S56–S61.
33. Villegas, R, Liu, S, Gao, YT, Yang, G, Li, H, Zheng, W, et al. Prospective study of dietary carbohydrates, glycemic index, glycemic load, and incidence of type 2 diabetes mellitus in middle-aged Chinese women. Arch Int Med 167:2 (2007), 310–316.
34. Aune, D, Norat, T, Romundstad, P, Vatten, LJ, Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose–response meta-analysis of cohort studies. Eur J Epidemiol 28 (2013), 845–858.
35. Hu, EA, Pan, A, Malik, V, Sun, Q, White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review. BMJ, 344, 2012, e1454.
36. Ezzati, M, Riboli, E., Behavioral and dietary risk factors for non-communicable diseases. N Engl J Med 369 (2013), 954–964.
37. He, Y, Ma, G, Zhai, F, Li, Y, Hu, Y, Feskens, EJM, et al. Dietary patterns and glucose tolerance abnormalities in Chinese adults. Diabetes Care, 32, 2009, 1972.
38. Li, G, Zhang, P, Wang, J, Gregg, EW, Yang, W, Gong, Q, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing diabetes prevention study: a 20-year follow-up study. Lancet, 371, 2008, 1783.